This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Texas A&M University System. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovations of Venkata Siva Charan Devanaboyina
Introduction
Venkata Siva Charan Devanaboyina is an accomplished inventor based in Fremont, CA. He has made significant contributions to the field of medical technology, particularly in the development of fusion proteins for therapeutic applications. With a total of 2 patents to his name, his work focuses on innovative methods for depleting target antigen-specific antibodies.
Latest Patents
His latest patents include a method of depleting target antigen-specific antibodies from a patient by administering a fusion protein known as 'Seldeg'. This fusion protein comprises a targeting component that specifically binds to a cell surface receptor or other cell surface molecule at near-neutral pH. The antigen component is designed to specifically bind to a target antigen-specific antibody. The method involves administering the Seldeg to a patient, effectively depleting the target antigen-specific antibodies.
Another patent details fusion proteins (Seldegs) for selectively depleting antigen-specific antibodies and methods of use thereof. This patent reiterates the innovative design of the Seldeg, emphasizing its potential in therapeutic applications for patients with specific antibody-related conditions.
Career Highlights
Venkata Siva Charan Devanaboyina is affiliated with The Texas A&M University System, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative medical solutions.
Collaborations
Some of his notable coworkers include Elizabeth Sally Ward Ober and Raimund Johannes Ober, who contribute to the collaborative environment that fosters innovation and research excellence.
Conclusion
Venkata Siva Charan Devanaboyina exemplifies the spirit of innovation in the medical field through his groundbreaking work on fusion proteins. His contributions are paving the way for new therapeutic approaches that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile